Sema3A and Sema3F are on the one hand known in the literature as guidance molecules for axons and OPCs in the developing nervous system and are also upregulated in MS brains in glial cells and neurons in the vicinity of active demyelinating lesions. This evidence concerns the gene SEMA3A and myeloid sarcoma.